Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after o
-
ENHERTU® Approved in the U.S. as First HER2 Directed Therapy for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following Disease Progression After One or More Endocrine Therapies
-
EdgeCortix SAKURA-I AI Accelerator Demonstrates Robust Radiation Resilience, Suitable for Many Orbital and Lunar Expeditions.
-
NinjaOne Announces Intent to Acquire SaaS Backup and Data Protection Leader Dropsuite
-
Eversource Energy Announces Sale of Aquarion Water Company
-
EastGroup Properties Announces the Income Tax Treatment of its 2024 Distributions
-
Silver Elephant Increases Non-Brokered Private Placement to $420,000 and Closes First Tranche for $330,000
-
Quantum Announces the Next Steps of its Debt Reduction Initiative
-
AST SpaceMobile Announces Closing of Private Offering of $460.0 Million of Convertible Senior Notes Due 2032
-
JAG, CP Capital Deliver J Veridian at Upper Dublin in Greater Philadelphia Area
-
zTrip Expands to Las Vegas: Setting a New Standard in Transportation Services
-
ROSEN, A LEADING LAW FIRM, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NXT
-
BetterWay Blood Testing Named SXSW Innovation Awards Finalist in Health & Biotech Category
-
K2 Gold Warrant Extension
-
Aimbridge Hospitality Set to Prioritize Growth and Results in 2025 Following a Year of Transformation
-
ROSEN, A LEADING LAW FIRM, Encourages MGP Ingredients, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MGPI
-
KBRA Assigns AA- Rating, Stable Outlook to Triborough Bridge and Tunnel Authority Subordinate Revenue Bond Anticipation Notes, Series 2025A
-
Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client
-
HF Sinclair Corporation Announces Redemption of HollyFrontier Corporation’s 5.875% Senior Notes due 2026
-
Oxford Park Income Fund, Inc. Announces December Net Asset Value and Declaration of Distributions for the Months Ending April, May, and June 2025
-
Drugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering
-
E2SOL and BK Energy MOU Signing at CES25
-
IBEX Limited to Announce Second Quarter 2025 Financial Results on February 6th, 2025
-
Wellfield Provides Corporate Update
-
Regal Rexnord Corporation Declares Quarterly Dividend of $.35 per share
-
Bryan Maher Joins The RMR Group to Head Investor Relations
-
Hola Prime Announces Exclusive Prime Bowl 5-Day Trading Competition Challenge
-
Eldorado Updates Lamaque Complex Technical Report; Demonstrating Significant Value and Potential to Extend Mine Life to 17 Years
-
Sceptre Ventures Announces Appointment of New President, Chief Executive Officer and Director
-
GT Holdings Announces Results for Financial Year Ended September 30, 2024
-
German American Bancorp, Inc. (GABC) Posts Strong 4th Quarter and Annual 2024 Earnings; Declares 7.4% Cash Dividend Increase
-
Brompton Energy Split Corp. Announces Preferred Share Distribution Rate
-
Arizona Entrepreneurs Award President Donald Trump with a Lifetime Achievement Award
-
MIKE TYSON, WINNIE HARLOW, PESO PLUMA, JA RULE, PAUL POGBA AND MORE ATTEND THE 2025 PEGASUS WORLD CUP
-
Sera Prognostics to Host Virtual R&D Day on January 31
-
Vortex Metals Announces Extension of Non-Brokered Private Placement
-
Dramatic Increase in Gold Recovery Significantly Improves the Business Options for Past-Producing High-Grade Gold Zinc Estrades Mine - Scoping Study to be Initiated
-
Northland Power Announces its Fourth Quarter 2024 Financial Results Release Date and Provides Investor Call and Webcast Details
-
Teradyne Declares Quarterly Cash Dividend
-
Brown & Brown, Inc. announces fourth quarter 2024 results, including total revenues of $1.2 billion, an increase of 15.4%; Organic Revenue growth of 13.8%; diluted net income per share of $0.73; and D
-
TDG Gold Upsizes Non-Brokered Private Placement
-
ROSEN, A LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
-
ROSEN, A LEADING LAW FIRM, Encourages Celanese Corporation Investors to Inquire About Securities Class Action Investigation - CE
-
Legend Power Systems Announces Closing of Final Tranche of Non-Brokered Private Placement
-
Brown & Brown, Inc. announces fourth quarter 2024 results, including total revenues of $1.2 billion, an increase of 15.4%; Organic Revenue growth of 13.8%; diluted net income per share of $0.73; a
-
Tavern 101 Feeds Over 1,500 First Responders Battling California Wildfires
-
Ovintiv Names Terri King to Board of Directors
-
IIE CEO Dr. Allan E. Goodman Will Leave Role After Decades of Impact on International Education
-
Hamilton ETFs Launches the “WIN”ners of its New HAMILTON CHAMPIONS™ Suite of ETFs
-
General Mills Completes Sale of Canadian Yogurt Business and Updates Fiscal 2025 Outlook for Recent Portfolio Reshaping Activity
